Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High-Throughput Proteomics in Lymphangioleiomyomatosis

CHEST Journal(2025)10.1016/j.chest.2025.12.026Source: DataRank Database

High-Throughput Proteomics in Lymphangioleiomyomatosis is a research paper published in CHEST Journal (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.82)OA: greenTopics (23)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Tiegang Han,Wendy K. Steagall ORCID,Samer Taha Salem,Damir Khabibullin ORCID,Joelle Chami

Live enrichment

PubMed:41482115 OpenAlex:https://openalex.org/W7117773171

Fondation pour la Recherche Médicale

Grant: FDM202306017195

University of Pennsylvania The Orphan Disease Center

Grant: GR1001319

National Heart Lung and Blood Institute Division of Intramural Research

Grant: HL131022

Fondation du Souffle

Grant: GR0122805

Fondation du Souffle

Grant: U01HL131022

FWCI

1.82

Citation Percentile

0.9%

Citation Trend

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13181220/

publisherhttps://api.elsevier.com/content/article/PII:S0012369225059616?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0012369225059616?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chest.2025.12.026

Fields of Study

Tuberous Sclerosis Complex ResearchEosinophilic Disorders and SyndromesAcute Myeloid Leukemia Research

MeSH Terms

AdultEnzyme-Linked Immunosorbent AssayFemaleHumansLung NeoplasmsMiddle AgedNeutrophilsBiomarkers, TumorBiomarkersCase-Control StudiesLymphangioleiomyomatosisMatrix Metalloproteinase 8ProteomicsVascular Endothelial Growth Factor D

Keywords

ProteomicsLymphangioleiomyomatosisProteasesAnalytePrecision medicineLung

Sustainable Development Goals

SDG 0: Good health and well-being

High-Throughput Proteomics in Lymphangioleiomyomatosis: Premelanosome Protein as a Diagnostic Biomarker, Construction of a Diagnosis Score, and Evidence of Neutrophil Involvement

10.6084/m9.figshare.32167608.v1figshare

High-Throughput Proteomics in Lymphangioleiomyomatosis: Premelanosome Protein as a Diagnostic Biomarker, Construction of a Diagnosis Score, and Evidence of Neutrophil Involvement

10.6084/m9.figshare.32167608figshare